A shingle manufacturing plant has been in talks with West Dallas community members to negotiate an exit strategy. Those talks are at a standstill.
GAF wants to wind down operations by 2029. Some West Dallas community members want the plant to leave sooner.A shingle manufacturing plant has sat in West Dallas for over seven decades. GAF, the owner of the factory and the largest roofing and waterproofing manufacturer in North America, has been trying to devise an exit strategy with residents in the area, but those negotiations have all but fallen apart in recent months.
Raul Reyes Jr., president of West Dallas 1, one of the neighborhood advocacy groups involved in the negotiations, said the community had some conversations with GAF in the hopes of reaching an agreement to leave sooner than 2029. “We think that’s too long of a period,” he said. The company saysBut two months ago, Reyes said the discussions fell apart. “That’s because at the end of the day, they came back to us with ‘Look, leaving any time sooner than 2029 is not on the table,’” Reyes said.
But to get that zoning change, the company will need some buy-in from the community, which it doesn’t have yet, according to Janie Cisneros. Cisneros lives within walking distance of the plant and has lived in the community nearly her whole life. She said her father died of cancer, her mother’s health is compromised and her daughter suffers from asthma. She suspects pollution to be the cause of all this. A 2020 emissions report by Paul Quinn College named the factory the primary source of air pollution in Dallas County.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
5 things you need to know about Medicare drug price negotiationsMany steps remain before older adults see the benefit of the Centers for Medicare and Medicaid Services' upcoming talks with drugmakers.
Leer más »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
Leer más »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs
Leer más »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
Leer más »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
Leer más »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
Leer más »